See the DrugPatentWatch profile for Rubraca
The price of Rubraca (rucaparib) varies depending on factors such as insurance coverage, pharmacy, and whether a patient is using a discount program. However, without insurance, the estimated retail price for a 30-day supply can be approximately $15,000 or more [1].
How can I get help paying for Rubraca?
For patients facing financial challenges in affording Rubraca, there are patient assistance programs available. The Rubraca Patient Assistance Program can help eligible individuals by covering the cost of their medication [1]. Additionally, many pharmaceutical companies offer co-pay cards that can reduce out-of-pocket expenses for insured patients [1]. Eligibility for these programs typically depends on income and insurance status [1].
What is Rubraca used for?
Rubraca is a PARP inhibitor used in the treatment of certain types of cancer. It is indicated for the maintenance treatment of adult patients with recurrent ovarian germ cell tumors, fallopian tube, or primary peritoneal cancer, or in patients with BRCA-mutated (germline and/or somatic) advanced ovarian germ cell tumors, fallopian tube, or primary peritoneal cancer who have been treated with two or more prior chemotherapy regimens [2]. It is also used for patients with certain BRCA-mutated (germline and/or somatic) metastatic castration-resistant prostate cancer who have been treated with at least one androgen receptor-directed therapy and an